🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our experience at Wake Forest Urology with "single-docking" robotic nephroureterectomy is feasible with good short-term outcomes. Check out our narrative review here! #UTUC #BeyondTheAbstract #RoboticSurgery International Journal of Urology and Nephrology Society of Urologic Oncology UroToday.com urotoday.com/recent-abstrac…

We are excited to have you here Parth Thakker, MD!

Honored and thankful to receive the @ReprodMed_SMRU Society for the Study of Male Reproduction Traveling Scholar Award to the #ASRM2023 meeting! Excited to present all of our research from the past year. Special thanks to Josh White and @ranjithramamd Desai Sethi Urology Institute for their support and mentorship!

Thank you to the Argentine Society of Urology Sociedad Argentina de Urología🇦🇷 and President Miguel Ángel Costa for this recognition! I am humbled to receive The Federico Texo Medal from the SAU, during the SAU Congress 2023. The 100 years event! Confederación Americana de Urología (CAU) Oficina Residentes CAU Wake Forest Urology

Great collaboration and work by Parth Thakker, MD and Wake Forest Urology and Tim Lyon Laura Geldmaker

Our world class medical oncologists presenting on the intricacies of advanced testis cancer and the use of high dose chemotherapy at ASCO. Nabil Adra and Lawrence Einhorn in the front row. IU Simon Comprehensive Cancer Center Indiana University Department of Urology #GU

Very proud of our 1st and 2nd year urologic oncology fellows Jiping 'Jay' Zeng, MD and Parth Thakker @ GU ASCO ‘25 presenting our work Indiana University Department of Urology IU Simon Comprehensive Cancer Center on ctDNA in GCTs and stage II Embryonal predominant GCT outcomes RPLND vs. chemotherapy

Our fellows regularly present abstracts at ASCO and at Amer. Urol. Assn.. This year, both Jiping 'Jay' Zeng, MD and Parth Thakker, MD presented on the outcomes of stage 2 EC predominant undergoing RPLND vs chemotherapy & the role of ctDNA in GCT under Timothy Masterson and Clint Cary, MD MPH MBA.

This year, we welcomed Jeffrey Holzbeierlein for our Donohue visiting professorship. Great lectures on NMIBC, leadership, nephrectomy in silverback gorillas, and case presentations by residents of Indiana University Department of Urology. Thanks to Clint Cary, MD MPH MBA and Tim Masterson for organizing. IU Simon Comprehensive Cancer Center Society of Urologic Oncology

Treating metastatic seminoma? Considering offering primary RPLND for early CS2 disease? Learn about the dissemination pattern of the disease and if a modified template is appropriate for these patients. Journal of Urology Jiping 'Jay' Zeng, MD Clint Cary, MD MPH MBA

Congratulations to our PGY 2 Connor Drake and Society of Urologic Oncology fellows, Parth Thakker, MD & Jiping 'Jay' Zeng, MD with the mentorship of Tim Masterson and Clint Cary, MD MPH MBA. Best poster award was given for their work regarding the utility of ctDNA in testicular germ cell tumor. IU Simon Comprehensive Cancer Center Indiana University Department of Urology